{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:43:05Z","timestamp":1770270185478,"version":"3.49.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167107","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T13:31:54Z","timestamp":1481203914000},"page":"e0167107","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Simultaneous Quantification of Antidiabetic Agents in Human Plasma by a UPLC\u2013QToF-MS Method"],"prefix":"10.1371","volume":"11","author":[{"given":"Mariana Millan","family":"Fachi","sequence":"first","affiliation":[]},{"given":"Let\u00edcia Bonancio","family":"Cerqueira","sequence":"additional","affiliation":[]},{"given":"Let\u00edcia Paula","family":"Leonart","sequence":"additional","affiliation":[]},{"given":"Thais Martins Guimar\u00e3es de","family":"Francisco","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":true,"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"issue":"9786","key":"ref1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: from pathophysiology to prevention and management","volume":"378","author":"CJ Nolan","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.paed.2013.03.004","article-title":"Type 2 diabetes mellitus: incidence, management and prognosis","volume":"23","author":"T Barrett","year":"2013","journal-title":"Paediatr Child Health"},{"key":"ref3","unstructured":"IDF. International Diabetes Federation\u2014DIABETES ATLAS. 7 ed2015 Sep."},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2337\/diacare.27.8.2067","article-title":"Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies","volume":"27","author":"S Klein","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: Current role in type 2 diabetes mellitus","volume":"65","author":"AJ Krentz","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2217\/dmt.10.22","article-title":"International diabetes center treatment of type 2 diabetes glucose algorithm","volume":"1","author":"G Simonson","year":"2011","journal-title":"Diabtes Manag"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology\u2013Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan\u2013 2015","volume":"21","author":"Y Handelsman","year":"2015","journal-title":"Endocr Pract"},{"issue":"1","key":"ref8","first-page":"S1","article-title":"Standards of Medical Care in Diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"ref9","unstructured":"Sociedade Brasileira de Diabetes. Conduta Terap\u00eautica no Diabetes Tipo 2: Algoritmo 2015. Posicionamento oficial SBD n\u00b002. 2015: 1\u201336."},{"issue":"6","key":"ref10","first-page":"1","article-title":"Metformin: an old but still the best treatment for type 2 diabetes","volume":"5","author":"LB Rojas","year":"2013","journal-title":"Diabetol Metab Syndr"},{"issue":"9922","key":"ref11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: Perspectives on the past, present, and future","volume":"383","author":"SE Kahn","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2013.06.007","article-title":"The early treatment of type 2 diabetes","volume":"126","author":"RE Pratley","year":"2013","journal-title":"Am J Med"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2011.04.006","article-title":"Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes","volume":"33","author":"F Ovalle","year":"2011","journal-title":"Clin Ther"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"SE Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"JS Kang","year":"2009","journal-title":"The Korean journal of internal medicine"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13300-013-0034-y","article-title":"Adherence to therapies in patients with type 2 diabetes","volume":"4","author":"LE Garcia-Perez","year":"2013","journal-title":"Diabetes therapy: research, treatment and education of diabetes and related disorders"},{"issue":"2011","key":"ref17","first-page":"1","article-title":"Guideline on bioanalytical method validation","volume":"44","year":"2012","journal-title":"Committee for Medicinal Products for Human Use"},{"key":"ref18","unstructured":"Food and Drug Administration. Guidance for Industry. Bioanalytical method validation. 2001."},{"key":"ref19","unstructured":"RDC 27 de 17 de maio de 2012: Disp\u00f5e sobre os requisitos m\u00ednimos para a valida\u00e7\u00e3o de m\u00e9todos bioanal\u00edticos empregados em estudos com fins de registro de medicamentos, (2012)."},{"issue":"1\u20132","key":"ref20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02320468","article-title":"An Improved High-Performance Liquid-Chromatographic Determination of Chlorpropamide in Human Plasma","volume":"39","author":"MT Bakare","year":"1994","journal-title":"Chromatographia"},{"key":"ref21","first-page":"S8","article-title":"Long-term sustained glycaemic control with liraglutide and glimepiride (both plus metformin), with added benefits of weight loss and less hypoglycaemia with liraglutide: 2-year LEAD-2 data","volume":"52","author":"A Frid","year":"2009","journal-title":"Diabetol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clinbiochem.2007.07.025","article-title":"A simple and rapid HPLC method for the detection of glyburide in plasma original research communication (analytical)","volume":"41","author":"C Gedeon","year":"2008","journal-title":"Clin Biochem"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1185\/03007990902869102","article-title":"Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes","volume":"25","author":"Y-L He","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0091270006299137","article-title":"Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT","volume":"47","author":"Y-L He","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jchromb.2014.08.019","article-title":"A validated liquid chromatography tandem mass spectrometry method for simultaneous determination of pioglitazone, hydroxypioglitazone, and ketopioglitazone in human plasma and its application to a clinical study","volume":"969","author":"M Kawaguchi-Suzuki","year":"2014","journal-title":"J Chromatogr B"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.aca.2007.08.004","article-title":"Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent","volume":"599","author":"D Malli","year":"2007","journal-title":"Anal Chim Acta"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1507\/endocrj.K06-052","article-title":"Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing","volume":"54","author":"M Matsuki","year":"2007","journal-title":"Endocr J"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jchromb.2007.10.010","article-title":"Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: An OPRU Network study","volume":"860","author":"SB Naraharisetti","year":"2007","journal-title":"J Chromatogr B"},{"issue":"12","key":"ref29","first-page":"1378","article-title":"Rapid high performance liquid chromatographic determination of chlorpropamide in human plasma","volume":"6","author":"MTB Odunola","year":"2007","journal-title":"Afr J Biotechnol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpba.2014.03.042","article-title":"Simultaneous determination of oral antidiabetic drugs in human plasma using microextraction by packed sorbent and high-performance liquid chromatography","volume":"96","author":"IMD Viana","year":"2014","journal-title":"J Pharmaceut Biomed"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.talanta.2007.01.042","article-title":"Simultaneous determination of rosiglitazone and metformin in plasma by gradient liquid chromatography with UV detection","volume":"72","author":"C Yardimci","year":"2007","journal-title":"Talanta"},{"issue":"1\u20132","key":"ref32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jchromb.2007.04.032","article-title":"Simultaneous assay of metformin and glibenclamide in human plasma based on extraction-less sample preparation procedure and LC\/(APCI)MS","volume":"854","author":"C Georgita","year":"2007","journal-title":"J Chromatogr B"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.talanta.2014.08.037","article-title":"Sequential hollow-fiber liquid phase microextraction for the determination of rosiglitazone and metformin hydrochloride (anti-diabetic drugs) in biological fluids","volume":"131","author":"GM Ben-Hander","year":"2015","journal-title":"Talanta"},{"issue":"11\u201312","key":"ref34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1365\/s10337-008-0633-3","article-title":"Development and validation of LC-UV for simultaneous estimation of rosiglitazone and glimepride in human plasma","volume":"67","author":"JN Jingar","year":"2008","journal-title":"Chromatographia"},{"issue":"6","key":"ref35","first-page":"728","article-title":"Validation of a Hplc Method for the Simultaneous Analysis of Metformin and Gliclazede in Human Plasma","volume":"57","author":"MC Ranetti","year":"2009","journal-title":"Farmacia"},{"issue":"1","key":"ref36","first-page":"153","article-title":"Pharmacokinetic studies of metformin and glibenclamide in normal human volunteers","volume":"27","author":"A Rashid","year":"2014","journal-title":"Pak J Pharm Sci"},{"key":"ref37","first-page":"A102","article-title":"Quantification of gliclazide, glipizide, glimepiride, pioglitazone, repaglinide and rosiglitazone in human plasma using reverse-phase high-performance liquid chromatography","author":"R Tirumala","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s13738-015-0637-5","article-title":"Development of liquid chromatographic method for the simultaneous determination of metformin and miglitol in human plasma: application to pharmacokinetic studies","volume":"12","author":"MV Attimarad","year":"2015","journal-title":"J Iran Chem Soc"},{"issue":"1\u20133","key":"ref39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.forsciint.2012.08.014","article-title":"Rapid extraction, identification and quantification of oral hypoglycaemic drugs in serum and hair using LC-MS\/MS","volume":"223","author":"TM Binz","year":"2012","journal-title":"Forensic Sci Int"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/chrsci\/49.2.94","article-title":"Simultaneous determination and pharmacokinetic study of metformin and rosiglitazone in human plasma by HPLC-ESI-MS","volume":"49","author":"L Chen","year":"2011","journal-title":"J Chromatogr Sci"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00216-011-4698-8","article-title":"Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry","volume":"400","author":"C Hess","year":"2011","journal-title":"Anal Bioanal Chem"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1373\/clinchem.2005.050864","article-title":"Identification and quantification of 8 sulfonylureas with clinical toxicology interest by liquid chromatography-ion-trap tandem mass spectrometry and library searching","volume":"51","author":"G Hoizey","year":"2005","journal-title":"Clin Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchromb.2013.04.024","article-title":"Development and validation of highly selective and robust method for simultaneous estimation of pioglitazone, hydroxypioglitazone and metformin in human plasma by LC-MS\/MS: Application to a pharmacokinetic study","volume":"930","author":"B Jagadeesh","year":"2013","journal-title":"J Chromatogr B"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/bmc.2768","article-title":"Simultaneous quantification of metformin and glipizide in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study","volume":"27","author":"N Li","year":"2013","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jchromb.2003.11.019","article-title":"Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry","volume":"801","author":"ZJ Lin","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/abio.2000.4597","article-title":"Identification of sulfonylureas in serum by electrospray mass spectrometry","volume":"282","author":"F Magni","year":"2000","journal-title":"Anal Biochem"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1570-0232(01)00618-3","article-title":"Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry","volume":"773","author":"HH Maurer","year":"2002","journal-title":"J Chromatogr B"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/bmc.723","article-title":"Simultaneous determination of metformin and glipizide in human plasma by liquid chromatography-tandem mass spectrometry","volume":"21","author":"CG Ding","year":"2007","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpba.2007.06.003","article-title":"Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasma","volume":"45","author":"HN Mistri","year":"2007","journal-title":"J Pharmaceut Biomed"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jchromb.2014.04.039","article-title":"Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study","volume":"960","author":"XJ Ni","year":"2014","journal-title":"J Chromatogr B"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jchromb.2014.06.023","article-title":"Simultaneous determination of metformin and vildagliptin in human plasma by a HILIC-MS\/MS method","volume":"965","author":"R Pontarolo","year":"2014","journal-title":"J Chromatogr B"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/chromsci\/bmv055","article-title":"Development and Validation of a Method for Simultaneous Estimation of Metformin and Sitagliptin in Human Plasma by LC-MS-MS and Its Application in a Bioequivalence Study","volume":"53","author":"S Reddy","year":"2015","journal-title":"J Chromatogr Sci"},{"issue":"11\u201312","key":"ref53","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1365\/s10337-009-1056-5","article-title":"LC-MS-MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence Study","volume":"69","author":"P Sengupta","year":"2009","journal-title":"Chromatographia"},{"issue":"15","key":"ref54","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1039\/C5AY00342C","article-title":"A sensitive and selective liquid chromatography mass spectrometry method for simultaneous estimation of anti-diabetic drugs inhibiting DPP-4 enzyme in human plasma: overcoming challenges associated with low recovery and sensitivity","volume":"7","author":"S Shantikumar","year":"2015","journal-title":"Anal Methods-Uk"},{"issue":"1\u20132","key":"ref55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jchromb.2007.04.002","article-title":"Simultaneous determination of metformin and rosiglitazone in human plasma by liquid chromatography\/tandem mass spectrometry with electrospray ionization: Application to a pharmacokinetic study","volume":"854","author":"L Zhang","year":"2007","journal-title":"J Chromatogr B"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jms.907","article-title":"Simultaneous determination of metformin and gliclazide in human plasma by liquid chromatography-tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers","volume":"40","author":"GP Zhong","year":"2005","journal-title":"J Mass Spectrom"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2005-2323","article-title":"The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes","volume":"91","author":"G Sesti","year":"2006","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Y Shu","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10038-006-0087-0","article-title":"Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin","volume":"52","author":"E Shikata","year":"2007","journal-title":"J Hum Genet"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1172\/JCI32133","article-title":"Pharmacogenetics of metformin response: a step in the path toward personalized medicine","volume":"117","author":"ML Reitman","year":"2007","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:42:36Z","timestamp":1540201356000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167107"}},"subtitle":[],"editor":[{"given":"John Matthew","family":"Koomen","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167107","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}